InhaleRx Limited (AU:IRX) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
InhaleRx Limited has announced a significant change in the director’s interests, with Director James Barrie acquiring 492,792 fully paid ordinary shares in lieu of accrued director fees, valued at $16,500. This move reflects the company’s ongoing adjustments in its governance and financial strategies.
For further insights into AU:IRX stock, check out TipRanks’ Stock Analysis page.